CN101628056A - Compound laxative hypoglycemic mixture - Google Patents
Compound laxative hypoglycemic mixture Download PDFInfo
- Publication number
- CN101628056A CN101628056A CN200910017381A CN200910017381A CN101628056A CN 101628056 A CN101628056 A CN 101628056A CN 200910017381 A CN200910017381 A CN 200910017381A CN 200910017381 A CN200910017381 A CN 200910017381A CN 101628056 A CN101628056 A CN 101628056A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- semen trichosanthis
- semen
- fructus aurantii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 10
- 150000001875 compounds Chemical class 0.000 title claims abstract description 7
- 230000002218 hypoglycaemic effect Effects 0.000 title abstract 2
- 239000008141 laxative Substances 0.000 title abstract 2
- 230000002475 laxative effect Effects 0.000 title abstract 2
- 210000000582 semen Anatomy 0.000 claims abstract description 24
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 239000000706 filtrate Substances 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000009636 Huang Qi Substances 0.000 claims description 11
- 230000002040 relaxant effect Effects 0.000 claims description 5
- 239000002893 slag Substances 0.000 claims description 4
- 206010010774 Constipation Diseases 0.000 abstract description 15
- 239000003814 drug Substances 0.000 abstract description 14
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 8
- 244000144730 Amygdalus persica Species 0.000 abstract 2
- 241000382455 Angelica sinensis Species 0.000 abstract 2
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 2
- 235000006533 astragalus Nutrition 0.000 abstract 2
- 241001061264 Astragalus Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241000219061 Rheum Species 0.000 abstract 1
- 240000004980 Rheum officinale Species 0.000 abstract 1
- 235000008081 Rheum officinale Nutrition 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 6
- 230000013872 defecation Effects 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 230000008506 pathogenesis Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000001502 supplementing effect Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 229940071462 oralone Drugs 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 208000018522 Gastrointestinal disease Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000010643 digestive system disease Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 208000018685 gastrointestinal system disease Diseases 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 108010075254 C-Peptide Proteins 0.000 description 1
- 235000006693 Cassia laevigata Nutrition 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000012239 Developmental disease Diseases 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- 208000027776 Extrapyramidal disease Diseases 0.000 description 1
- 208000001287 Galactorrhea Diseases 0.000 description 1
- 206010017600 Galactorrhoea Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 241000522641 Senna Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Natural products C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 1
- -1 anthracene glycoside Chemical class 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- DCSUBABJRXZOMT-IRLDBZIGSA-N cisapride Chemical compound C([C@@H]([C@@H](CC1)NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)OC)N1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-IRLDBZIGSA-N 0.000 description 1
- 229960005132 cisapride Drugs 0.000 description 1
- DCSUBABJRXZOMT-UHFFFAOYSA-N cisapride Natural products C1CC(NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)C(OC)CN1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-UHFFFAOYSA-N 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229940095399 enema Drugs 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 229940124513 senna glycoside Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to the field of medicament formulas, in particular to a compound laxative and hypoglycemic mixture, which is prepared by soaking astragalus, rehmannia root, figwort root, Chinese angelica, bitter orange, tuber fleeceflower root, peach seed, semen trichosanthis and rhubarb serving as raw materials in water, decocting and removing residues to obtain filtrate, and is technically characterized in that the mixture comprises the following raw materials in percentage by weight: 12-23 parts of astragalus membranaceus, 12-22 parts of radix rehmanniae, 8-10 parts of radix scrophulariae, 12-16 parts of angelica sinensis, 4-6 parts of fructus aurantii, 10-14 parts of polygonum multiflorum, 10-12 parts of peach kernels, 8-10 parts of semen trichosanthis and 2-3 parts of rheum officinale. The invention has the advantages of definite curative effect, low cost and no toxic or side effect, and is used for treating diabetic constipation.
Description
Technical field
The present invention relates to a kind of Chinese patent medicine preparation, specifically a kind of compound composition for relaxing bowels and lowering sugar that is used for the treatment of diabetic constipation.
Background technology
As everyone knows, along with people living condition's improvement, the change of life style, the sickness rate of diabetes and complication raises day by day, the diabetic gastrointestinal disease is the common chronic complicating diseases of diabetes, prevalence is 30%-76%, and the constipation common sympton that is the diabetes gastrointestinal disease accounts for 60%, its pathogenesis still imperfectly understands, may be because hyperglycemia effect and Developmental and Metabolic Disorder cause neural malnutrition, domination gastrointestinal nerve damage.
Western medicine does not still have the specific treatment ways and means at present, symptomatic treatment medicine commonly used: cisapride sheet, phenolphthalein tablets etc., but part patient has dizziness, distending pain in the head, drowsiness, reactions such as tongue is numb, abdominal discomfort, arrhythmia, can not tolerate, the case report that gynecomasty, galactorrhea, convulsibility epilepsy, The extrapyramidal symptoms and frequent micturition were once arranged, limited its clinical practice, the people's health in serious threat, and quality of life is descended comprehensively.
Summary of the invention
Purpose of the present invention is exactly in order to overcome above-mentioned existing technical deficiency, and a kind of determined curative effect is provided, and is with low cost, the compound composition for relaxing bowels and lowering sugar that has no side effect.
The technical scheme that the present invention solves the problems of the technologies described above employing is: a kind of compound composition for relaxing bowels and lowering sugar, and adopting the Radix Astragali, the Radix Rehmanniae, Radix Scrophulariae, Radix Angelicae Sinensis, Fructus Aurantii, Radix Polygoni Multiflori, Semen Persicae, Semen Trichosanthis, Radix Et Rhizoma Rhei is raw material, is soaked in water, remove slag after decocting filtrate, its technical characterictic is, raw material is formed and is by weight percentage: the Radix Astragali 12~23, the Radix Rehmanniae 12~22, Radix Scrophulariae 8~10, Radix Angelicae Sinensis 12~16, Fructus Aurantii 4~6%, Radix Polygoni Multiflori 10~14, Semen Persicae 10~12, Semen Trichosanthis 8~10, Radix Et Rhizoma Rhei 2~3.
The invention has the beneficial effects as follows, determined curative effect, with low cost, have no side effect.
The specific embodiment
The invention will be further described below in conjunction with embodiment:
Embodiment 1:
Adopting the Radix Astragali, the Radix Rehmanniae, Radix Scrophulariae, Radix Angelicae Sinensis, Fructus Aurantii, Radix Polygoni Multiflori, Semen Persicae, Semen Trichosanthis, Radix Et Rhizoma Rhei is that feedstock production forms, and its component (weight %) is the Radix Astragali 20, the Radix Rehmanniae 16, Radix Scrophulariae 10, Radix Angelicae Sinensis 14, Fructus Aurantii 6, Radix Polygoni Multiflori 10, Semen Persicae 11, Semen Trichosanthis 10, Radix Et Rhizoma Rhei 3 is got 58 kilograms of above-mentioned nine kinds of raw material gross weights, after selected the cleaning, with 20000ml water logging bubble 3-4 hour, decoct 60 minutes then at ambient temperature, through the routine filtration of removing slag, high pressure, behind the sterilization process, gained filtrate 9000ml, sterile bag packing, sealing, every bag of 150ml.Early, late twice (medicine) being taken before meal, each oral one bag, 10 days is a course of treatment, each course of treatment is every three days, takes three courses of treatment of mixture of the present invention continuously.
Therapeutic Principle of the present invention: diabetic constipation belongs to quench one's thirst constipation category in the deteriorated case of the traditional Chinese medical science, and the scorching blood stasis of deficiency of qi and yin is important pathogenesis, runs through primary disease all the time.Diabetic constipation be the course of disease with the passing of time, the scorching blood stasis of deficiency of qi and yin more very, cloudy body fluid deficiency void, large intestine not flourish and conduct unable due to, its pathogenesis is the cloudy body fluid deficiency of gas, the dryness of the intestine blood stasis, so treat with supplementing QI and nourishing YIN, moisturize purge heat, blood circulation promoting and blood stasis dispelling is rule.In the component of the present invention: Radix Astragali invigorating the spleen and benefiting QI, Radix Rehmanniae nourishing YIN and clearing away heat, promote the production of body fluid, the two is a monarch drug, supplementing QI and nourishing YIN promotes the production of body fluid, intestine moistening dry with relieving constipation, the pathogenesis that hits and quench one's thirst, modern pharmacological research shows that the Radix Astragali has dual regulation to blood glucose, the diabetic plasma insulin of promotion and the excretory effect of C peptide are arranged, and the Radix Rehmanniae can obviously reduce the hyperglycemia level, increases hepatic glycogen content.Radix Scrophulariae, Radix Angelicae Sinensis, Radix Polygoni Multiflori are ministerial drug, share the yin nourishing of enriching blood, promote the production of body fluid that to moisturize be supplementing fluid to relax the bowels, with loosening bowel to relieve constipation." Required Readings for Medical Professionals ": " method is worked as invigorating QI and blood, and body fluid is given birth to then from logical justice." the modern pharmacological research Radix Scrophulariae has slight blood sugar lowering, promotes the local blood circulation effect that Radix Angelicae Sinensis, Radix Polygoni Multiflori can promote enterokinesia and slight discharge function is arranged.The Fructus Aurantii conducting blood to flow downwards, Semen Persicae disperse blood stasis and dredge collateral, loosening bowel to relieve constipation, Semen Trichosanthis relieving stuffiness in the epigastrium eliminating stagnation, loosening bowel to relieve constipation is adjuvant drug altogether, and pharmacological research shows that Semen Persicae is rich in fatty oil Castor Oil intestinal, is beneficial to defecation, and Semen Trichosanthis has the laxation effect down of rushing down.Get Radix Et Rhizoma Rhei detoxifcation the turbid descending less.Purge heat, relieving constipation, be messenger drug, Radix Et Rhizoma Rhei rushes down down that effective ingredient is the anthracene glycoside, mainly is the Senna fruit glycoside, site of action can increase enterokinesia and suppress the enteral moisture absorption mainly at large intestine, promotes defecation.All medicines share profit and do not grow greasy, cool and impairment of YIN not, supplementing QI and nourishing YIN, the blood stasis dispelling intestine moistening makes three warmers fluent, constipation is dredged and is separated.The present invention has the adjusting gastrointestinal function, promotes enterokinesia, constipation relieving symptom, but auxiliary adjustment blood glucose effect simultaneously, and clinical practice treatment diabetic constipation is obtained good efficacy.
Embodiment 2:
Adopting the Radix Astragali, the Radix Rehmanniae, Radix Scrophulariae, Radix Angelicae Sinensis, Fructus Aurantii, Radix Polygoni Multiflori, Semen Persicae, Semen Trichosanthis, Radix Et Rhizoma Rhei is that feedstock production forms, and its component (weight %) is the Radix Astragali 18, the Radix Rehmanniae 18, Radix Scrophulariae 10, Radix Angelicae Sinensis 13, Fructus Aurantii 6, Radix Polygoni Multiflori 11, Semen Persicae 12, Semen Trichosanthis 9, Radix Et Rhizoma Rhei 3 is got 58 kilograms of above-mentioned nine kinds of raw material gross weights, after selected the cleaning, with 20000ml water logging bubble 3-4 hour, decoct 60 minutes then at ambient temperature, through the routine filtration of removing slag, high pressure, behind the sterilization process, gained filtrate 9000ml, sterile bag packing, sealing, every bag of 150ml.Early, late twice (medicine) being taken before meal, each oral one bag, 10 days is a course of treatment, each course of treatment is every three days, takes three courses of treatment of mixture of the present invention continuously.
But each raw material of the present invention also blended embodiment of the listed ratio of according to the form below (percentage by weight) is realized.Its processing technique is identical with embodiment 1.
Embodiment | The Radix Astragali | The Radix Rehmanniae | Radix Scrophulariae | Radix Angelicae Sinensis | Fructus Aurantii | Radix Polygoni Multiflori | Semen Persicae | Semen Trichosanthis | Radix Et Rhizoma Rhei |
??3 | ??12 | ??22 | ??8 | ??16 | ??4 | ??14 | ??11 | ??10 | ??3 |
??4 | ??23 | ??15 | ??10 | ??12 | ??6 | ??10 | ??12 | ??10 | ??2 |
??5 | ??23 | ??12 | ??9 | ??15 | ??6 | ??14 | ??10 | ??8 | ??3 |
??6 | ??17 | ??20 | ??9 | ??14 | ??5 | ??12 | ??12 | ??9 | ??2 |
Below in conjunction with my institute, promptly the clinical preliminary test that carries out of Shandong Province Wendeng Central Hospital, Weihai City is done further, is described in detail the present invention:
1, case is selected: this organizes 60 examples, male 32 examples, women 28 examples, age 21-64 year, 40 years old mean age, course of disease 2-27, average 10.2 years.
2, Therapeutic Method: early, late twice (medicine) being taken before meal, each oral one bag, 10 days is a course of treatment, and continuously took the present invention three courses of treatment every three days each course of treatment.
3, diagnostic criteria: observe the diagnostic criteria that case diabetes diagnosis standard all meets WHO proposition in 1997, and there is defecation in various degree to require great effort, constipation with dry stool, clinical manifestations such as defecation frequency minimizing, get rid of the serious heart, brain, kidney complication, colon, rectum organic disease are got rid of in the barium enema of x line, and Metcalf improves and simplifies technical measurement colon transhipment time (CTT) all above upper limits of normal 56 hours.
4, criterion of therapeutical effect: formulate with reference to relevant criterion in " traditional Chinese medical science disease diagnosis criterion of therapeutical effect " and " the new Chinese medicine clinical research guideline (trying) ".Cure: in two days defecation once, just matter is changeed profit, unobstructed when separating just, short-term does not have recurrence.Effectively: in three days defecation once, just matter is changeed profit, separates and just owes smooth.Do not heal: symptom do not have obvious improvement or during treating the recurrence in addition increase the weight of.
5, therapeutic outcome: the present invention treats 60 examples, takes medicine three courses of treatment, cures 14 examples, effective 42 examples, invalid 4 examples, cure rate 23%, effective percentage 70%, inefficiency 7%, total effective rate 93%.
Claims (1)
1, a kind of compound composition for relaxing bowels and lowering sugar, adopting the Radix Astragali, the Radix Rehmanniae, Radix Scrophulariae, Radix Angelicae Sinensis, Fructus Aurantii, Radix Polygoni Multiflori, Semen Persicae, Semen Trichosanthis, Radix Et Rhizoma Rhei is raw material, is soaked in water, remove slag after decocting filtrate, its technical characterictic is, raw material is formed and is by weight percentage: the Radix Astragali 12~23, the Radix Rehmanniae 12~22, Radix Scrophulariae 8~10, Radix Angelicae Sinensis 12~16, Fructus Aurantii 4~6%, Radix Polygoni Multiflori 10~14, Semen Persicae 10~12, Semen Trichosanthis 8~10, Radix Et Rhizoma Rhei 2~3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100173813A CN101628056B (en) | 2009-08-05 | 2009-08-05 | Compound composition for treating diabetic constipation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100173813A CN101628056B (en) | 2009-08-05 | 2009-08-05 | Compound composition for treating diabetic constipation |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101628056A true CN101628056A (en) | 2010-01-20 |
CN101628056B CN101628056B (en) | 2011-04-20 |
Family
ID=41573446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100173813A Expired - Fee Related CN101628056B (en) | 2009-08-05 | 2009-08-05 | Compound composition for treating diabetic constipation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101628056B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103494939A (en) * | 2013-10-14 | 2014-01-08 | 丰建君 | Traditional Chinese medicine for treating senile habitual constipation |
CN104758714A (en) * | 2015-05-04 | 2015-07-08 | 刘成玲 | Traditional Chinese medicine for treating spleen and stomach weakness type diabetes constipation |
CN104800582A (en) * | 2015-05-13 | 2015-07-29 | 关庆玲 | Traditional Chinese medicine for treating internal heat due to yin deficiency type diabetic constipation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101095829A (en) * | 2007-07-05 | 2008-01-02 | 北京艺信堂医药研究所 | Chinese traditional medicine preparations for treating diabetes constipation |
CN101095828A (en) * | 2007-07-05 | 2008-01-02 | 北京艺信堂医药研究所 | Chinese traditional medicine composition for treating diabetes constipation |
CN101129771A (en) * | 2007-08-27 | 2008-02-27 | 尹克华 | Traditional Chinese medicine for treating bradykinesia type constipation |
-
2009
- 2009-08-05 CN CN2009100173813A patent/CN101628056B/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103494939A (en) * | 2013-10-14 | 2014-01-08 | 丰建君 | Traditional Chinese medicine for treating senile habitual constipation |
CN104758714A (en) * | 2015-05-04 | 2015-07-08 | 刘成玲 | Traditional Chinese medicine for treating spleen and stomach weakness type diabetes constipation |
CN104800582A (en) * | 2015-05-13 | 2015-07-29 | 关庆玲 | Traditional Chinese medicine for treating internal heat due to yin deficiency type diabetic constipation |
Also Published As
Publication number | Publication date |
---|---|
CN101628056B (en) | 2011-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101947284B (en) | Traditional Chinese medicinal composition for treating diabetes and preparation method thereof | |
CN102228603B (en) | Chinese medicine for treating retention of urine | |
CN104352991A (en) | Traditional Chinese medicine preparation for treating gout and preparation method thereof | |
CN103007206A (en) | Oral liquid for treating chronic atrophic gastritis | |
CN103301400A (en) | Traditional Chinese medicinal composition for treating chronic atrophic gastritis and preparation method of traditional Chinese medicinal composition | |
CN102319353B (en) | Traditional Chinese drug enema for treating abdominal distension after gynecological operation | |
CN101628056B (en) | Compound composition for treating diabetic constipation | |
CN101530489B (en) | Chinese medicine composition used for treating non-active stage infiltrative exophthalmos of thyroid-associated ophthalmopathy and preparation method thereof | |
CN103800842A (en) | Traditional Chinese medicine composition for treating carcinoma of urinary bladder | |
CN103417716B (en) | Hypoglycemic Tongluo tablet for treating diabetic peripheral neuropathy | |
CN101623416A (en) | Traditional Chinese medicine preparation for postpartum recovery of women | |
CN105456689A (en) | Traditional Chinese medicine composition for treating diabetes as well as preparation method and application of traditional Chinese medicine composition | |
CN102335367B (en) | Medicine for treating pelvic inflammation | |
CN101700390B (en) | Oral traditional Chinese medicine composition for treating fatty liver | |
CN105233078A (en) | Traditional Chinese medicine composition for treating viral hepatitis | |
CN110755501A (en) | Traditional Chinese medicine composition for treating diabetic peripheral neuropathy | |
CN104622995A (en) | Pharmaceutical composition for treating chronic superficial gastritis and preparation method of pharmaceutical composition | |
CN112386634A (en) | Traditional Chinese medicine composition for treating senile constipation | |
CN104491316B (en) | A kind of Chinese medicine preparation for the treatment of deficiency of QI in middle-JIAO type hyperplasia of prostate | |
CN114732883B (en) | Traditional Chinese medicine composition for strengthening spleen and tonifying stomach as well as preparation method and application thereof | |
CN102100853B (en) | Traditional Chinese medicine for treating gout and preparation method thereof | |
CN116440224B (en) | Traditional Chinese medicine composition, preparation and preparation method | |
CN102935214A (en) | Traditional Chinese medicinal composition for treating uremia | |
CN100586451C (en) | Creeping euphorbia oral liquid for treating chronic ulcerative colitis and its preparation | |
CN105169199A (en) | Traditional Chinese medicinal composition for treating functional dyspepsia with syndrome of liver-stomach disharmony |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110420 Termination date: 20110805 |